NATtrol™ SARS-CoV-2 (recombinant) Stock

NATtrol™ SARS-CoV-2 (recombinant) Stock* is formulated with purified, intact bacterial cells containing synthetic SARS-CoV-2 sequence. The cells have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol™ SARS-CoV-2 (recombinant) Stock in a purified protein matrix.

CT Range: 22-25

INTENDED USE:

NATtrol™ SARS-CoV-2 (recombinant) Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 N gene. NATtrol™ SARS-CoV-2 (recombinant) Stock can also be used for validation of clinical assays, development of diagnostic tests and training of laboratory personnel.

Product PDF

For Research Use Only